N-Acetyl Semax Amide
NASA · Semax amidate · N-acetyl-semax-amide · C39H54N10O10S · monoisotopic 854.3806 Da. The index holds 89 assay reports on this compound across 20 batches from 12 suppliers.
Analytical fingerprint
Hand-authored chemistry. These properties describe the substance and do not change when a record is added.
Two modifications on the semax scaffold, and both can be individually missing, giving four possible species within 42 Da of each other. Partially-modified material is common: the index's NASA records show a mean 2.3 % combined des-acetyl and free-acid content, which is high enough that the compound's effective purity as sold is materially below its stated purity. The record page breaks out each modification state separately.
- Compound class
- Neuroactive and cognitive peptides
- Molecular formula
- C39H54N10O10S
- Monoisotopic mass
- 854.3806Da
- Average mass
- 854.98Da
- Residues
- 7
- Nominal retention (RG-2, 30 min)
- 7.62min
- Retention window
- 0.25min
- Counter-ion as usually shipped
- acetate
- Typical label claims
- 5 mg · 10 mg · 20 mg
- Analytical difficulty (index scale)
- 0.85 — straightforward
- Purity is a defined quantity
- YES
Representative chromatogram
Drawn from this page's own medians. Not a scan, not an illustration, and not any single report.
What the index has observed
Arithmetic over the 89 records the index holds. Aggregates on this page are computed over the records the index holds, which are not a random sample of the material on the market. Lots that get tested are lots someone chose to test. Read every figure here as a description of this dataset rather than as an estimate of a population.
By supplier
Suppliers with fewer than two purity records on this compound are omitted from the figure rather than drawn as a line. The full table, including the thin cells, is on the by-supplier page.
Characteristic impurities and degradants
The left three columns are authored chemistry — what this molecule characteristically carries and where it elutes. The right three are what the index has actually reported.
| Named species | ΔRT (min, RG-2) | Δ mass (Da) | Seen in | Median % area | Max % area |
|---|---|---|---|---|---|
| Met sulfoxide (+16 Da) | -0.34 | +15.995 | 98% | 0.13 | 1.36 |
| des-acetyl amide (−42 Da) | -0.40 | -42.011 | 92% | 0.12 | 0.69 |
| semax (des-acetyl, des-amide, −41 Da) | -0.56 | -41.027 | 84% | 0.14 | 0.83 |
| N-acetyl semax free acid (+1 Da) | +0.22 | +0.984 | 84% | 0.23 | 1.38 |
Degradation pathways
- acetyl loss
- C-terminal amide hydrolysis
- Met oxidation
Full impurity profile, with what each named species implies about the synthesis →
Quarterly coverage
Most recent records
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043368 | CPC | CPC-2602-D2941 | Medutest | 2026-Q3 | 98.79 | 6.05 | 102.1 | Supplier-supplied | 0 | PASS |
| AX-2026-043574 | BCH | BCH-2602-E8253 | Janoshik | 2026-Q3 | 97.75 | 8.85 | 97.9 | Supplier-supplied | 1 | FAIL |
| AX-2026-043575 | BCH | BCH-2602-E8253 | Janoshik | 2026-Q3 | 97.44 | 9.19 | 104.8 | Supplier-supplied | 1 | FAIL |
| AX-2026-043367 | CPC | CPC-2602-D2941 | Nordanalyt | 2026-Q3 | 99.39 | 6.16 | 92.4 | Supplier-supplied | 0 | PASS |
| AX-2026-043573 | BCH | BCH-2602-E8253 | Janoshik | 2026-Q3 | 97.47 | 8.59 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043576 | BCH | BCH-2602-E8253 | Janoshik | 2026-Q3 | 97.46 | 9.53 | 92.4 | Laboratory-retained | 1 | FAIL |
| AX-2026-042746 | GGPeps | GGPE-2512-A1206 | PeptideMeter | 2026-Q2 | 98.97 | 6.67 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042234 | Homopeptide | HOMO-2603-C1382 | Janoshik | 2026-Q2 | 98.99 | 8.00 | 99.6 | Supplier-supplied | 0 | PASS |
| AX-2026-042747 | GGPeps | GGPE-2512-A1206 | Janoshik | 2026-Q2 | 98.25 | 7.00 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042235 | Homopeptide | HOMO-2603-C1382 | Janoshik | 2026-Q2 | 99.22 | 8.28 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042233 | Homopeptide | HOMO-2603-C1382 | Janoshik | 2026-Q2 | 99.74 | 8.09 | 93.9 | Supplier-supplied | 0 | PASS |
| AX-2026-042745 | GGPeps | GGPE-2512-A1206 | Janoshik | 2026-Q2 | 98.71 | 6.87 | 92.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042748 | GGPeps | GGPE-2512-A1206 | Janoshik | 2026-Q2 | 98.71 | 7.41 | 93.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043229 | SGN | SGN-2508-K1228 | VendorInvestigate | 2026-Q1 | 98.90 | 7.29 | 106.8 | Buyer-sourced | 0 | PASS |
| AX-2026-043233 | SGN | SGN-2508-K1228 | Janoshik | 2026-Q1 | 99.68 | 8.16 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043231 | SGN | SGN-2508-K1228 | PeptideMeter | 2026-Q1 | 99.48 | 7.57 | 99.0 | Supplier-supplied | 0 | PASS |
| AX-2026-043230 | SGN | SGN-2508-K1228 | Janoshik | 2026-Q1 | 99.93 | 7.33 | 93.8 | Supplier-supplied | 0 | PASS |
| AX-2026-043232 | SGN | SGN-2508-K1228 | Medutest | 2026-Q1 | 99.20 | 7.73 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043228 | SGN | SGN-2508-K1228 | Medutest | 2026-Q1 | 99.55 | 7.62 | 94.7 | Supplier-supplied | 0 | PASS |
| AX-2026-042956 | KP | KP-2508-D4657 | PeptideMeter | 2025-Q4 | 98.99 | 7.34 | 97.3 | Supplier-supplied | 1 | FAIL |
| AX-2026-041837 | JEEP | JEEP-2507-U3035 | Medutest | 2025-Q4 | 99.66 | 8.49 | 100.1 | Supplier-supplied | 0 | PASS |
| AX-2025-019027 | JEEP | JEEP-2507-U3035 | Janoshik | 2025-Q4 | 99.93 | 8.47 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019019 | JEEP | JEEP-2507-U3035 | Medutest | 2025-Q4 | 99.93 | 8.39 | 92.6 | Supplier-supplied | 0 | PASS |
| AX-2025-019018 | JEEP | JEEP-2507-U3035 | Janoshik | 2025-Q4 | 99.84 | 8.49 | 92.7 | Supplier-supplied | 0 | PASS |
| AX-2025-019022 | JEEP | JEEP-2507-U3035 | Janoshik | 2025-Q4 | 99.84 | 9.08 | 90.1 | Supplier-supplied | 0 | PASS |